Related references
Note: Only part of the references are listed.Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries
Robert Cohen et al.
EXPERT REVIEW OF VACCINES (2017)
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design
Emma Rey-Jurado et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing
Zhong Peng et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Angela Huttner et al.
LANCET INFECTIOUS DISEASES (2017)
A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail
Debra A. Goff et al.
LANCET INFECTIOUS DISEASES (2017)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
Robert W. Frenck et al.
VACCINE (2017)
Vaccine development to prevent Staphylococcus aureus surgical-site infections
N. Mohamed et al.
BRITISH JOURNAL OF SURGERY (2017)
Human capital gaps in vaccine development: an issue for global vaccine development and global health
Andrea Cawein et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Respiratory Syncytial Virus Infection An Illness for All Ages
Edward E. Walsh
CLINICS IN CHEST MEDICINE (2017)
Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field
Jan T. Poolman et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Escherichia coli Harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States
Patrick McGann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol
Julia Simioni et al.
BMC PEDIATRICS (2016)
Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine
Sara Tomczyk et al.
CLINICAL INFECTIOUS DISEASES (2016)
Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention
Gustavo H. Dayan et al.
EXPERT REVIEW OF VACCINES (2016)
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011
Katherine E. Fleming-Dutra et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion
Marian L. Gaviola et al.
PHARMACOTHERAPY (2016)
Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection
Laura A. Mike et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
Geert Leroux-Roels et al.
VACCINE (2016)
A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults
Eric Sheldon et al.
VACCINE (2016)
Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
Germie P. J. M. van den Dobbelsteen et al.
VACCINE (2016)
Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers
Nicole Bezay et al.
VACCINE (2016)
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
Guy de Bruyn et al.
VACCINE (2016)
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
Marc Lipsitch et al.
MBIO (2016)
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study
Matthew R. Moore et al.
LANCET RESPIRATORY MEDICINE (2016)
One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A
Francesca Mancini et al.
PLOS ONE (2016)
Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study
Silvia Arboleya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Varicella Skin Complications in Childhood: A Case Series and a Systematic Review of the Literature
Elena Bozzola et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis
John C. Kash et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O. Ngwuta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response
Leire Aguinagalde et al.
PLOS ONE (2015)
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Mirjam J. Knol et al.
EMERGING INFECTIOUS DISEASES (2015)
Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status
Goncalo Matias et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2014)
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
Michael T. Brady et al.
PEDIATRICS (2014)
The contribution of vaccination to global health: past, present and future
Brian Greenwood
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Vaccines against gonorrhea: Current status and future challenges
Ann E. Jerse et al.
VACCINE (2014)
Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review
Stefan H. E. Kaufmann et al.
LANCET RESPIRATORY MEDICINE (2014)
Emergence and global spread of epidemic healthcare-associated Clostridium difficile
Miao He et al.
NATURE GENETICS (2013)
Intrawound Vancomycin Powder Reduces Surgical Site Infections in Posterior Cervical Fusion
Cyrus Caroom et al.
SPINE (2013)
Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae
Urban Lundberg et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993-2008
Hong Zhou et al.
CLINICAL INFECTIOUS DISEASES (2012)
Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines
Lee M. Hampton et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults
Kyle Widmer et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Mario Raviglione et al.
LANCET (2012)
Effect of a Best-Practice Alert on the Rate of Influenza Vaccination of Pregnant Women
Timothy E. Klatt et al.
OBSTETRICS AND GYNECOLOGY (2012)
A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential
Timothy F. Landers et al.
PUBLIC HEALTH REPORTS (2012)
Adherence to Surgical Care Improvement Project Measures and Post-Operative Surgical Site Infections
Samir S. Awad
SURGICAL INFECTIONS (2012)
Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae
Thomas Tangden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
Timothy R. Walsh et al.
LANCET INFECTIOUS DISEASES (2011)
Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine
Charles F. von Reyn et al.
AIDS (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Invasive group B streptococcal disease in an orthopaedic unit
P. J. Jenkins et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination
H. J. Adam et al.
VACCINE (2010)
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease
Inci Yildirim et al.
VACCINE (2010)
Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Dongeun Yong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Effect of Universal Influenza Immunization on Antibiotic Prescriptions: An Ecological Study
Jeffrey C. Kwong et al.
CLINICAL INFECTIOUS DISEASES (2009)
Staphylococcal Vaccines and Immunotherapies
Adam C. Schaffer et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Staphylococcus aureus antigens and challenges in vaccine development
John R. Middleton
EXPERT REVIEW OF VACCINES (2008)
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (RSV) vaccines - Nonadjuvanted vaccine or vaccine adjuvanted with alum - Given concomitantly with influenza vaccine to high-risk elderly individuals
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Nonimmunodominant regions are effective as building blocks in a Streptococcal fusion protein vaccine
Margaretha Stalhammar-Carlemalm et al.
CELL HOST & MICROBE (2007)
Antimicrobial resistance in Haemophilus influenzae
Stephen Tristram et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Effectiveness of inactivated influenza vaccine for prevention of otitis media in children
Senem Konuk Ozgur et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Decreasing prevalence of β-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States
KP Heilmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antibacterial resistance worldwide: causes, challenges and responses
SB Levy et al.
NATURE MEDICINE (2004)
How do viral infections predispose patients to bacterial infections?
C Beadling et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2004)
Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States
K Hasegawa et al.
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE (2003)
The PROTEKT surveillance study:: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections
D Hoban et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
A European study on the relationship between antimicrobial use and antimicrobial resistance
SLAM Bronzwaer et al.
EMERGING INFECTIOUS DISEASES (2002)
Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory, syncytial virus subunit vaccines
EAF Simoes et al.
VACCINE (2001)
Share Paper
